Research, analysis, and perspectives on enterprise AI, computational biotech, and the future of on-premise intelligence.
★ Featured
Security. Intelligence. Biology. Three pillars define our 2026 vision — watch the story unfold through immersive video and visual storytelling.
NovaGenAI builds custom AI models that convert biological datasets into machine-readable formats for drug discovery.
Regulated industries can't send data to the cloud. On-premise AI powered by NVIDIA DGX is the infrastructure shift.
From chatbots to fully autonomous systems — what AI agents are, how they work, and why enterprises deploy them.
Everything about NVIDIA's desktop AI supercomputer — specs, use cases, and why it changes on-premise AI.
The definitive comparison of AI deployment models. Cost, security, latency, compliance — broken down.
How NovaGenAI builds custom models on proprietary biological data, inspired by Google's research.
Google's research converts single-cell RNA data into natural language. What it means for biotech AI.
From drug discovery to protein folding — computational modelling cuts years off research timelines.
The evolution from single-omics to multi-omics AI and why integrating data types unlocks better predictions.
AI is compressing drug discovery timelines from a decade to months. How computational approaches reshape pharma.
Enterprise voice AI handles complex conversations, integrates with business systems, and operates in regulated environments.
90% of enterprise data is unstructured. AI document intelligence extracts, classifies, and acts on it.
Off-the-shelf models aren't enough. How enterprises build custom LLMs on their own data.
Complete guide to NVIDIA's AI software ecosystem — what each tool does and why enterprises need the full stack.
NovaGenAI's blog covers enterprise AI infrastructure, computational biotech, autonomous AI agents, voice AI, on-premise AI deployment, NVIDIA AI stack, LLM engineering, document intelligence, drug discovery, and multi-omics analysis — with a focus on practical enterprise deployment in regulated industries.
NovaGenAI's blog is written by Don Calaki (Founder & CEO) and the NovaGenAI engineering team, drawing on real enterprise AI deployment experience at CryoCord Group and deep technical expertise in NVIDIA infrastructure, computational biology, and AI systems engineering.
NovaGenAI publishes new blog posts regularly, covering deep technical topics in enterprise AI, computational biotech, and AI infrastructure. Posts are research-backed and reflect real production deployment experience.